Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,069,000 | 1,246,000 | 3,267,000 | 7,646,000 | 12,283,000 |
| Depreciation Amortization | 2,852,000 | 3,282,000 | 4,583,000 | 2,518,000 | 2,550,000 |
| Accounts receivable | 152,000 | 311,000 | -383,000 | 755,000 | -1,108,000 |
| Accounts payable and accrued liabilities | 114,000 | 2,089,000 | 414,000 | -1,311,000 | 467,000 |
| Other Working Capital | -49,000 | 2,508,000 | 166,000 | -706,000 | -897,000 |
| Other Operating Activity | -2,814,000 | -2,378,000 | -647,000 | -1,954,000 | -5,474,000 |
| Operating Cash Flow | $3,324,000 | $7,058,000 | $7,400,000 | $6,948,000 | $7,821,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 283,000 | 34,000 | 130,000 | 3,619,000 | -2,743,000 |
| PPE Investments | -1,281,000 | -854,000 | -673,000 | -473,000 | -737,000 |
| Net Acquisitions | -3,025,000 | -4,461,000 | -1,158,000 | -1,187,000 | 1,772,000 |
| Purchase Of Investment | -57,000 | -130,000 | -91,000 | -46,000 | -11,000 |
| Sale Of Investment | 93,000 | 59,000 | 38,000 | 43,000 | N/A |
| Purchase Sale Intangibles | -330,000 | -1,740,000 | -1,281,000 | -3,947,000 | -458,000 |
| Other Investing Activity | -252,000 | -1,680,000 | -1,135,000 | -3,815,000 | -303,000 |
| Investing Cash Flow | $-4,239,000 | $-7,032,000 | $-2,889,000 | $-1,859,000 | $-2,022,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -630,000 | 520,000 | -5,000 | 687,000 | 46,000 |
| Debt Issued | 5,928,000 | 919,000 | N/A | 1,980,000 | N/A |
| Debt Repayment | -884,000 | -750,000 | N/A | -1,750,000 | N/A |
| Common Stock Issued | 43,000 | 279,000 | 482,000 | 429,000 | 409,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -2,635,000 | -6,015,000 |
| Dividend Paid | -3,486,000 | -3,521,000 | -3,461,000 | -3,665,000 | -3,764,000 |
| Other Financing Activity | -93,000 | -152,000 | -63,000 | 31,000 | 3,000 |
| Financing Cash Flow | $878,000 | $-2,705,000 | $-3,047,000 | $-4,923,000 | $-9,321,000 |
| Exchange Rate Effect | -76,000 | -152,000 | -65,000 | -4,000 | -25,000 |
| Beginning Cash Position | 6,164,000 | 8,995,000 | 7,596,000 | 7,434,000 | 10,981,000 |
| End Cash Position | 6,051,000 | 6,164,000 | 8,995,000 | 7,596,000 | 7,434,000 |
| Net Cash Flow | $-113,000 | $-2,831,000 | $1,399,000 | $162,000 | $-3,547,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,324,000 | 7,058,000 | 7,400,000 | 6,948,000 | 7,821,000 |
| Capital Expenditure | -1,328,000 | -1,012,000 | -742,000 | -672,000 | -839,000 |
| Free Cash Flow | 1,996,000 | 6,046,000 | 6,658,000 | 6,276,000 | 6,982,000 |